Skip to content

Knowledge Hub

Learn how we're pioneering a new wave of precision medicine, explore our collection of publications, disease studies, webinars, thought leadership, and more

Newsletter signup

Publication

Genetic Risk Factors for Severe and Fatigue Dominant Long COVID

PrecisionLife identified the first detailed genetic risk factors for long COVID and common mechanisms with ME/CFS and other complex diseases

Publication

Genetic Risk Factors for ME/CFS Identified using Combinatorial Analysis

Groundbreaking study published in the Journal of Translational Medicine provides the first detailed genetic insights into the mechanisms underpinning ME/CFS

Publication

Cross-Disorder Patient and Mechanistic Stratification using Combinatorial Analyses

Our analyses indicate that subgroups of patients with CNS diseases have common pathophysiological drivers that may contribute to specific common clinical manifestations.

Publication

Combinatorial Analysis of ALS and FTD Patient Genomes to Identify Cross-Disease Mechanisms

Our analyses provides insights into subgroups of patients with ALS and FTD with common pathophysiological drivers that may underlie specific overlapping clinical manifestations, allowing us to develop precision medicine interventions targeted at mechanisms occurring in both diseases.

Publication

Patient Stratification of Asthma Population Reveals Distinct Genetic & Mechanistic Differences between T2-High and T2-Low Asthma

The PrecisionLife platform identified 2,483 SNPs that were highly associated with T2-high asthma and 1,182 SNPs in the T2-low cohort with only 36 common between the two datasets.

Publication

The Era of Precision Neuroscience

DDW Neuroscience Guide - Dr Steve Gardner presents how our precision neuroscience approach is benefitting pharmaceutical companies investing in CNS

Publication

Combinatorial analytics: An Essential Tool for the Delivery of Precision Medicine

An Opinion, published in the new Open Access Journal Artificial Intelligence in the Life Sciences from Elsevier, describes the need to extend our current analytical methods to effectively interrogate population data sets

Publication

Cell Patterns: INDx Systematic Indication Extension

Paper demonstrating the potential of indication extension to systematically reposition hundreds of drugs into new indications

Publication

Unlocking Precision Neuroscience and R&D Innovation

Precision Medicine Quarterly Q&A with Steve Gardner, CEO and Co-founder, PrecisionLife

Sign Up

Subscribe to our blog